SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-052235
Filing Date
2024-04-26
Accepted
2024-04-26 06:02:13
Documents
9
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A tm242716-1_def14a.htm DEF 14A 1665953
2 GRAPHIC bc_directors-4c.jpg GRAPHIC 90406
3 GRAPHIC bc_netloss-4c.jpg GRAPHIC 60066
4 GRAPHIC bc_tsr-4c.jpg GRAPHIC 81859
5 GRAPHIC lg_mersanatherapeu-4c.jpg GRAPHIC 27276
6 GRAPHIC px_24mersanaproxy01pg01-bw.jpg GRAPHIC 225062
7 GRAPHIC px_24mersanaproxy01pg02-bw.jpg GRAPHIC 212627
8 GRAPHIC sg_alejandracarvajal-bw.jpg GRAPHIC 11353
9 GRAPHIC sg_martinhuber-bw.jpg GRAPHIC 12635
  Complete submission text file 0001104659-24-052235.txt   2590493
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 24878386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)